We are live on ! Find out more
PM

Parametrica Management Portfolio holdings

AUM $88M
1-Year Est. Return 48.84%
This Fund
S&P 500
This Quarter Est. Return
+28.81%
1 Year Est. Return
+48.84%
3 Year Est. Return
+257.17%
5 Year Est. Return
+315.15%
10 Year Est. Return
–
AUM
$55.4M
AUM Growth
+$6.65M
Cap. Flow
-$139K
Cap. Flow %
-0.25%
Top 10 Hldgs %
76.73%
Holding
54
New
8
Increased
11
Reduced
5
Closed
28

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$3.86M
2
BEKE icon
KE Holdings
BEKE
+$3.77M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$3.15M
4
MSFT icon
Microsoft
MSFT
+$2.75M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$2.36M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$3.82M
2
JD icon
JD.com
JD
+$3.46M
3
BABA icon
Alibaba
BABA
+$3.27M
4
WOLF icon
Wolfspeed
WOLF
+$2.31M
5
IBB icon
iShares Biotechnology ETF
IBB
+$1.93M

Sector Composition

Rank Sector Weight
1 Communication Services 34.96%
2 Technology 28.81%
3 Healthcare 20.59%
4 Consumer Discretionary 8.71%
5 Real Estate 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QVCGA
51
DELISTED
QVC Group Inc Series A
QVCGA
– –
-432
Closed -$35.2K
NKLA
52
DELISTED
Nikola Corporation Common Stock
NKLA
– –
-497
Closed -$32K
TELL
53
DELISTED
Tellurian Inc.
TELL
– –
-11,300
Closed -$18.9K
WE
54
DELISTED
WeWork Inc.
WE
– –
-824
Closed -$47.1K
1 2
3

Similar funds

BCP
Balance Capital Partners New York $87.9M AUM
PBCM
Point Break Capital Management Miami, Florida $88M AUM
CVM
Civilization Ventures Management Belvedere Tiburon, California $87.9M AUM
XXIP
Xiamen Xinweidachuang Investment Partnership Xiamen, China $87.8M AUM 29.25% 1-Year Est. Return
DG
Daventry Group New York $87.8M AUM 3.83% 1-Year Est. Return
RFL
RD Finance Ltd Limassol, Cyprus $88.1M AUM 11.44% 1-Year Est. Return
IAP
Indie Asset Partners Carmel, Indiana $87.8M AUM 27.76% 1-Year Est. Return
MPEM
Marathon Partners Equity Management New York $88.3M AUM 20.65% 1-Year Est. Return

Parametrica Management's Q1 2023 Portfolio in Review

As of Q1 2023, Parametrica Management held 54 positions worth $55.4M, up 14% from $48.8M the previous quarter. Its ten largest holdings account for 77% of the portfolio.

Parametrica Management's Q1 2023 filing shows 8 new, 11 increased, 5 reduced and 28 closed positions. Its largest new stake was KE Holdings: 203,892 shares worth $3.84M. The largest sale was Pfizer, an estimated $3.82M.

By sector, the portfolio is most concentrated in Communication Services at 35% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.

  • Parametrica Management's largest Q1 2023 buy was KE Holdings: 203,892 shares worth $3.84M.
  • Parametrica Management added most to Meta Platforms (Facebook) in Q1 2023, an estimated $3.86M increase.
  • Parametrica Management's biggest Q1 2023 reduction was Alnylam Pharmaceuticals, cutting an estimated $746K.
  • Parametrica Management fully exited Pfizer in Q1 2023, selling an estimated $3.82M.
  • Parametrica Management's ten largest holdings make up 77% of its $55.4M portfolio in Q1 2023.
  • Parametrica Management opened 8 new positions and closed 28 in Q1 2023.
  • Parametrica Management's portfolio value rose 14% quarter-over-quarter to $55.4M.

Based on Parametrica Management's 13F filing for Q1 2023, filed 9 May 2023.